Ian Anglin, Ph.D.

Current

• Postdoctoral Scientist at University of Maryland

Past

• Postdoctoral Scientist at University of Maryland

Education

• Cardiff University / Prifysgol Caerdydd
• Cardiff University / Prifysgol Caerdydd

Connections

4 connections

Industry

Research

Ian Anglin, Ph.D.’s Summary

Selected Publications:

Anglin IE and Passaniti A (2004). Runx protein signaling in human cancers, Book chapter in: Molecular Targeting and Signal Transduction. Edited by Rakesh Kumar. Kluwer Academic Publishers, New York, NY. pp 189-216.

Partin JV, Anglin IE and Kyprianou N (2003). Quinazoline-based alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signaling and IkappaBalpha induction. Br. J. Cancer 88: 1615-1621.

Anglin IE, Glassman D and Kyprianou N (2002). Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis 5:88-95.

Glynne-Jones E, Harper ME, Seery LT, James R, Anglin I, Morgan HE, Taylor KM, Gee JM, Nicholson RI (2001). TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. Int J Cancer. 15:178-184.

Hopkinson I, Anglin IE, Lloyd-Evans D and Harding KG (1997). Collagen VII expression in human chronic wounds and scars. J Pathol 182: 192-196.

Ian Anglin, Ph.D.’s Specialties:

My background is molecular biology in human and life sciences.

Selected techniques of expertise include:
-Microarray analysis,
-siRNA technology,
-Real time-Polymerase Chain Reaction,
-Chromatin Immunoprecipitation (ChIP) assays,
-Trans Epithelial Electrical Resistance (TEER) assays,
-Adenovirus construction,
-Tet-off cell line construction,
-Enzyme-linked Immunosorbant assays (ELISA),
-Colony formation assays,
-Cell proliferation and migration assays.

Ian Anglin, Ph.D.’s Experience

• Postdoctoral Scientist

  University of Maryland

  (Educational Institution; 1001-5000 employees; Research industry)

  2003 — Present (6 years)

  Performed independent research in the areas of angiogenesis, carcinogenesis and lung disease.
  Supervised several graduate and undergraduate students.

• Postdoctoral Scientist

  University of Maryland

  (Educational Institution; 1001-5000 employees; Research industry)

  2000 — 2003 (3 years)

  Perfomed independent research into the effects of novel drug therapeutics for prostate cancer.
  Writing publications, grants and presentation of data at internal and external scientific meetings.

Ian Anglin, Ph.D.’s Education

• Cardiff University / Prifysgol Caerdydd

  PhD , Molecular Pathology , 1995 — 2000

  Activities and Societies:

  President, Postgraduate Society (1996)

• Cardiff University / Prifysgol Caerdydd

  B.Sc. , Biochemistry , 1990 — 1993

Additional Information

Ian Anglin, Ph.D.’s Honors:

Awarded American Foundation for Urologic Disease (AFUD) Postdoctoral Grant
Society for Basic Urological Research (SBUR) Travel Scholarship